Middle East Healthcare Company (TADAWUL:4009)
33.98
-0.02 (-0.06%)
May 21, 2026, 3:16 PM AST
TADAWUL:4009 Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 167.45 | 301.88 | 282 | 17.04 | 75.18 | 17.2 |
Depreciation & Amortization | 233.11 | 233.11 | 206.18 | 187.09 | 144.46 | 140.03 |
Other Amortization | 12.84 | 12.84 | 10.57 | 2.72 | 1.52 | 1.38 |
Loss (Gain) From Sale of Assets | -113.26 | -113.26 | -19.06 | 0.76 | 1.98 | 1.68 |
Asset Writedown & Restructuring Costs | - | - | -45.45 | - | - | - |
Loss (Gain) on Equity Investments | 13.86 | 13.86 | 0.52 | - | - | - |
Provision & Write-off of Bad Debts | 6.38 | 6.38 | -29.05 | 32.07 | 1.57 | -13.74 |
Other Operating Activities | 335.94 | 209.27 | 253.64 | 306.06 | 79.9 | 51.3 |
Change in Accounts Receivable | -76.38 | -76.38 | 383.19 | -697.84 | -354.04 | -32.89 |
Change in Inventory | 1.99 | 1.99 | 6.07 | 85.47 | 5.58 | -1.14 |
Change in Accounts Payable | -36.28 | -36.28 | -237.08 | 132.56 | 124.13 | -59.93 |
Change in Other Net Operating Assets | -8.83 | -8.83 | -45.53 | 125.15 | -4.24 | -27.27 |
Operating Cash Flow | 536.82 | 544.6 | 766 | 191.08 | 76.02 | 76.62 |
Operating Cash Flow Growth | -37.40% | -28.90% | 300.87% | 151.35% | -0.78% | - |
Capital Expenditures | -455.16 | -455.16 | -470.82 | -229.61 | -249.52 | -416.56 |
Sale of Property, Plant & Equipment | 127.91 | 127.91 | 21.5 | 0.38 | 0.13 | 0.13 |
Sale (Purchase) of Intangibles | -2.12 | -2.12 | -8.5 | -2.76 | -0 | -0.95 |
Investment in Securities | -9 | -9 | -51 | -10 | - | - |
Investing Cash Flow | -557.74 | -338.37 | -508.82 | -241.99 | -249.4 | -417.39 |
Long-Term Debt Issued | - | 1,204 | 1,597 | 1,566 | 1,182 | 1,105 |
Long-Term Debt Repaid | - | -1,189 | -2,656 | -1,330 | -951.39 | -705.91 |
Net Debt Issued (Repaid) | 14.54 | 14.54 | -1,059 | 235.88 | 230.49 | 399.11 |
Common Dividends Paid | -46.02 | -46.02 | - | - | - | - |
Other Financing Activities | -202.5 | -197.58 | 803.01 | -157.93 | -69.64 | -47.12 |
Financing Cash Flow | -233.98 | -229.06 | -256.07 | 77.95 | 160.85 | 351.99 |
Foreign Exchange Rate Adjustments | -3.15 | -3.15 | 6.75 | 1.77 | - | - |
Miscellaneous Cash Flow Adjustments | - | - | - | -0 | - | - |
Net Cash Flow | -258.05 | -25.98 | 7.86 | 28.82 | -12.53 | 11.22 |
Free Cash Flow | 81.67 | 89.44 | 295.18 | -38.53 | -173.5 | -339.94 |
Free Cash Flow Growth | -77.85% | -69.70% | - | - | - | - |
Free Cash Flow Margin | 2.61% | 2.88% | 10.24% | -1.45% | -8.06% | -18.15% |
Free Cash Flow Per Share | 0.89 | 0.97 | 3.21 | -0.42 | -1.89 | -3.69 |
Cash Interest Paid | 189.2 | 189.2 | 186.18 | 157.93 | 69.64 | 47.12 |
Levered Free Cash Flow | - | -194.66 | -150.59 | -107.96 | -281.13 | -392.73 |
Unlevered Free Cash Flow | - | -74.15 | -12.73 | -12.22 | -238 | -366.78 |
Change in Working Capital | -119.49 | -119.49 | 106.65 | -354.65 | -228.58 | -121.22 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.